In a raid on the weed smuggler's home ... Scrivens' cannabis profits were laundered to purchase these high-value art pieces. Scrivens, from the Welsh town of Ebbw Vale, admitted to importing ...

With just a few insider strategies, you can master the art of lawn care ... minimal effort and maximal satisfaction. Weed control is paramount in lawn care, acting as a guardian of your grass's health ...

Oct. 2, 2024 — Researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in ... Cannabinoid CBG Reduces ...

She’s all lazy… and boring.” This image of Sarah, reduced to a mere shell of her former self, was the centerpiece of an anti-marijuana campaign that sought to convey a powerful message ...

Marijuana’s humid growing conditions are a paradise for dangerous mold. States where marijuana is legal make growers hire laboratories to check for concentrations of mold and other contaminants ...

The ballot decisions Tuesday point to voter concerns that drug policies have drifted too far to the left, according to policy ...

It was a stunning morning back in July, one of those rare days when, by eight o’clock, the dew had already burnt off, the ...

More than a few mimicked MedMen's airy aesthetic. And as they battled to hold on to their ... In 2014, Forbes wrote a piece detailing the “8 hottest publicly traded marijuana companies” and Snyder ...

Marijuana stocks may seem a tempting investment, but make sure you're aware of the associated risks before diving into this burgeoning market. Many, or all, of the products featured on this page ...

Legalizing marijuana at the national level is generally popular with Americans — 57% of people say marijuana should be legal for both medical and recreational purposes, while 32% say it should ...

Election Day is Tuesday and in four states, voters will have the opportunity to cast their thoughts on the future of marijuana legislation. On the Florida ballot, Amendment 3 pertains to the ...

Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of Chemical & Engineering News. Vice President ...